共 50 条
- [31] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
- [32] Value of immunohistochemistry for detection of BRAF V600E mutation [J]. VIRCHOWS ARCHIV, 2020, 477 : S361 - S361
- [33] BRAF V600E in Pediatric Papillary Thyroid Carcinomas [J]. LABORATORY INVESTIGATION, 2014, 94 : 157A - 157A
- [34] BRAF V600E in Pediatric Papillary Thyroid Carcinomas [J]. MODERN PATHOLOGY, 2014, 27 : 157A - 157A
- [35] BRAF mutation in breast cancer by BRAF V600E mutation-specific antibody [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1545 - 1556
- [36] Oral Juvenile Xanthogranuloma: A Clinicopathological, Immunohistochemical and BRAF V600E Study of Five New Cases, with Literature Review [J]. HEAD & NECK PATHOLOGY, 2022, 16 (02): : 407 - 415
- [37] Oral Juvenile Xanthogranuloma: A Clinicopathological, Immunohistochemical and BRAF V600E Study of Five New Cases, with Literature Review [J]. Head and Neck Pathology, 2022, 16 : 407 - 415
- [39] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas [J]. FRONTIERS IN ONCOLOGY, 2018, 8
- [40] Amelanotic primary dermal melanoma with V600E BRAF mutation [J]. DERMATOLOGICA SINICA, 2017, 35 (02) : 110 - 111